When HIV AIDS was still considered a death sentence , some also claimed that treatments for it would bankrupt the health care system , as critics are claiming about the hepatitis C drug . But that did not happen . One reason is that cost containment is built into the system through the medicine life cycle . In its initial phases , innovator biopharmaceutical companies produce medical advances through pioneering scientific work and massive investments , like the 500 billion invested in research and development since 2000 . After that , competition enters the market and lower cost generics become available , helping achieve long term savings .
